Tag: car

WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the extinguishment of its convertible note with YA II PN, Ltd (“Yorkville”).  

HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility’s Peak Load Reduction program, a first in the nine-year history of the utility’s peak load reduction programs. Designed to alleviate strain on the power grid during summer months, the initiative will leverage ChargeScape’s AI-powered technology platform and aims to intelligently integrate more than 4,000 BMW EV drivers and 2,200 Ford EV drivers into the power grid. Participating customers will receive financial incentives for helping to support grid stability and community resilience through optimized EV charging.

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce the successful completion of dose level 1 for its first-in-human Phase I dose-escalation clinical trial (NCT05302037) (“ANGELICA Trial”) for four late stage cancer patients and is scheduled to start dose level 2 of the ANGELICA Trial in third quarter of 2025.

According to Towards Automotive consultants, the global electric vehicle tires market is projected to reach approximately USD 59.59 billion by 2034, increasing from USD 24.53 billion in 2024, at a CAGR of 9.45% during the forecast period 2025 to 2034.